7 Results for: created: (01/2018 to 01/2018)

People

  1. Rudin
    Rudin
  2. Kris
    Kris
  3. Li
    Li
  4. Pietanza
    Pietanza
  5. Rimner
    Rimner
  6. Bensman
    Bensman
  7. Bushnell
    Bushnell
  8. Chaft
    Chaft
  9. Delasos
    Delasos
  10. Drilon
    Drilon

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Solid Tumor Oncology Division (7)
  5. Thoracic Oncology (7)
  6. Center for Molecular Imaging and Biotechnology (4)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (3)
  8. Biostatistics Service (2)
  9. Department of Pathology and Laboratory Medicine (2)
  10. Epidemiology and Biostatistics (2)
  1. "Charles Rudin"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Solid Tumor Oncology Division (7)
  5. Thoracic Oncology (7)
  6. Center for Molecular Imaging and Biotechnology (4)

More Groups

People
  1. Charles Rudin (7)
  2. Andreas Rimner (2)
  3. Bob Li (2)
  4. Maria Pietanza (2)
  5. Mark Kris (2)
  6. Abraham Wu (1)

More People

Years
  1. 2017 (7)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Advances in Radiation Oncology (1)
  3. Annals of Translational Medicine (1)
  4. Translational Lung Cancer Research (1)
Publishers
  1. Elsevier Inc. (5)
  2. AME Publishing Company (1)
  3. Translational Lung Cancer Research (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety, clinical activity and biomarker results from a phase lb study of erlotinib plus atezolizumab in advanced NSCLC
    Meeting Abstract

    Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial
    Meeting Abstract

    Byers, L. A.; Krug, L.; Waqar, S.; Dowlati, A.; Hann, C.; Chiappori, A.; Owonikoko, T.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Single-agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC), in small-cell lung cancer (SCLC)
    Meeting Abstract

    Spigel, D.; Pietanza, M. C.; Bauer, T.; Ready, N.; Morgensztern, D.; Glisson, B. S.; Byers, L. A.; Johnson, M.; Burris, H.; Robert, F.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Small-cell lung cancer in the era of immunotherapy
    Journal Article

    Majem, M.; Rudin, C. M.
    Translational Lung Cancer Research (2017)

    Fulltext@MSK | Save
  • Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers
    Journal Article

    Li, B. T.; Stephens, D.; Chaft, J. E.; Rudin, C. M.; Jones, D. R.; Rusch, V. W.; Rimner, A.; Isbell, J. M.
    Annals of Translational Medicine (2017)

    Fulltext@MSK | Save
  • Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
    Journal Article

    Lok, B. H.; Ma, J.; Foster, A.; Perez, C. A.; Shi, W.; Zhang, Z.; Li, B. T.; Rudin, C. M.; Rimner, A.; Wu, A. J.
    Advances in Radiation Oncology (2017)

    Fulltext@MSK | Save